Pinnacle Associates’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.5M Sell
805,822
-4,485
-0.6% -$180K 0.37% 61
2026
Q1
$29.3M Sell
810,307
-27,948
-3% -$1.07M 0.38% 63
2025
Q4
$32.2M Buy
838,255
+3,215
+0.4% +$121K 0.41% 53
2025
Q3
$30.2M Buy
835,040
+6,483
+0.8% +$226K 0.4% 58
2025
Q2
$28.4M Buy
828,557
+300
+0% +$9.52K 0.41% 56
2025
Q1
$25.9M Hold
828,257
0.38% 63
2024
Q4
$26.5M Buy
+828,257
New +$26.9M 0.36% 65
2024
Q3
Sell
-819,660
Closed -$25.4M 836
2024
Q2
$25.4M Buy
819,660
+270,792
+49% +$8.07M 0.4% 66
2024
Q1
$16.3M Buy
+548,868
New +$15.6M 0.26% 104

Other funds holding QLTY

Pinnacle Associates's QLTY Position: Q2 2026 in Review

Pinnacle Associates reduced its GMO US Quality ETF (QLTY) stake by 0.55% in Q2 2026, selling an estimated $180K and leaving 805,822 shares worth $33.5M. The position accounts for 0.37% of the portfolio, ranked #61.

Pinnacle Associates first reported a position in QLTY in Q1 2024 and has held it in 9 quarters since. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Pinnacle Associates held 805,822 shares of GMO US Quality ETF worth $33.5M as of Q2 2026.
  • Pinnacle Associates sold 4,485 GMO US Quality ETF shares in Q2 2026, an estimated $180K.
  • GMO US Quality ETF made up 0.37% of Pinnacle Associates's portfolio in Q2 2026, its #61 holding.
  • Pinnacle Associates first reported a position in GMO US Quality ETF in Q1 2024 and has held it in 9 quarters since.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.